A randomized controlled trial of oral phosphate binders in the treatment of pseudoxanthoma elasticum
- 31 August 2011
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 65 (2), 341-348
- https://doi.org/10.1016/j.jaad.2010.05.023
Abstract
No abstract availableKeywords
Funding Information
- US Food and Drug Administration (FD-R-002161-01 and 02)
This publication has 17 references indexed in Scilit:
- Pseudoxanthoma Elasticum: Genetics, Clinical Manifestations and Therapeutic ApproachesSurvey of Ophthalmology, 2009
- Pseudoxanthoma Elasticum Is a Metabolic DiseaseJournal of Investigative Dermatology, 2009
- Pseudoxanthoma Elasticum-Like Phenotypes: More Diseases than OneJournal of Investigative Dermatology, 2007
- Oral phosphate binders in the treatment of pseudoxanthoma elasticumJournal of the American Academy of Dermatology, 2005
- Molecular genetics of pseudoxanthoma elasticum: a metabolic disorder at the environment–genome interface?Trends in Molecular Medicine, 2001
- Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticumNature Genetics, 2000
- Mutations in ABCC6 cause pseudoxanthoma elasticumNature Genetics, 2000
- Mutations of the gene encoding the transmembrane transporter protein ABC-C6 cause pseudoxanthoma elasticumJournal of Molecular Medicine, 2000
- Periumbilical pseudoxanthoma elasticum associated with chronic renal failure and angioid streaks—apparent regression with hemodialysisJournal of the American Academy of Dermatology, 1998
- Angioid streaksSurvey of Ophthalmology, 1982